CTOR
Citius Oncology, Inc.
Set alert
0.55 USD +0.02 +4.63%
0.5001 Day range 0.563
0.493 52-week range 1.75
- YTD
- -44.60%
- 1 year
- -67.98%
- Open
- 0.5274
- Prev close
- 0.5295
- Mkt cap
- 58.59M
- Vol
- 292.79K
- Avg vol
- 116.09K
- EPS
- -0.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5001
- High
- 0.563
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.37
- Inst. own
- 0.70%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.13
- 200-d avg
- 7.55
- 1y target
- 3.00
Financial health
Altman Z-Score
-2.35 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E -6.0×
FY 2022 5y median -33.1× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 3.3×
FY 2022 5y median 15.9× FY 2025
P/FCF -27.1×
FY 2022 5y median -864× FY 2025
EV/EBITDA -6.3×
FY 2022 5y median -5.7× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -3.7%
FY 2022 5y median -0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -55.2%
FY 2022 5y median -47.8% FY 2025
ROIC -45.7%
FY 2022 5y median -42.6% FY 2025
ROA -24.5%
FY 2022 5y median -25.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -14.3%
FY 2022 FY 2025
EPS (diluted) -13.3%
FY 2022 FY 2025
Free Cash Flow -4446.7%
FY 2022 FY 2025
Financial Health
Current Ratio 0.6×
FY 2022 5y median 0.4× FY 2025
Quick Ratio 0.1×
FY 2022 5y median 0.2× FY 2025
Debt / Equity 0.1×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.0×
FY 2022 5y median 0.0× FY 2025
Interest Coverage -108×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-09-30